Magna ease bioprosthetic aortic valve: mid-term haemodynamic outcomes in 1126 patients.

Stephen D ThorpJawad KhazaalGrace YuJessica L ParkerTomasz A Timek

Published in: Interactive cardiovascular and thoracic surgery (2021)

Magna Ease AVR maintained low mean transprosthetic gradients throughout mid-term evaluation and was associated with excellent overall survival and freedom from reoperation at nine years post implantation.

Keyphrases

aortic valve
transcatheter aortic valve replacement
aortic valve replacement
transcatheter aortic valve implantation
aortic stenosis
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
mitral valve
prognostic factors
peritoneal dialysis
heart failure
patient reported